NOVOZYMES BIOINDUSTRIAL A/S: Financial statements 2024
CVR: 24257908
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
NOVOZYMES BIOINDUSTRIAL A/S (CVR 24257908) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -51,118 and a net result of DKK -41,700 compared with DKK -4,027,032 the year before. Equity in the 2024 report amounted to DKK 24,935,237. The solvency ratio was 99.8%.
- Gross Profit
- DKK -51,118
- Profit/Loss
- DKK -41,700
- Equity
- DKK 24,935,237
- Total Assets
- DKK 24,984,671
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -51K | -42K | 24.9M | - |
| 2023 | - | -41K | -4M | 25M | - |
| 2022 | - | -37K | -3M | 29M | 0 |
| 2021 | - | -32K | 637K | 29.5M | 0 |
| 2020 | - | -32K | 2.5M | 28.8M | 0 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of September 18, 2024, Lisbet Kragelund has joined the board of directors of NOVOZYMES BIOINDUSTRIAL A/S.
As of September 18, 2024, Randi Camilla Kinch Jensen has left the board of directors of NOVOZYMES BIOINDUSTRIAL A/S.
As of September 18, 2024, Lisbet Kragelund is registered as director of NOVOZYMES BIOINDUSTRIAL A/S.
As of September 18, 2024, Randi Camilla Kinch Jensen has stepped down as adm. dir. of NOVOZYMES BIOINDUSTRIAL A/S.
NOVOZYMES BIOINDUSTRIAL A/S has published its annual report for 2023. Gross profit came to DKK -40,804, and the net result was DKK -4,027,032.
As of June 7, 2024, EY Godkendt Revisionspartnerselskab has been appointed auditor of NOVOZYMES BIOINDUSTRIAL A/S.
As of June 7, 2024, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of NOVOZYMES BIOINDUSTRIAL A/S.
About NOVOZYMES BIOINDUSTRIAL A/S
NOVOZYMES BIOINDUSTRIAL A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1974. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named NOVO NORDISK BIOINDUSTRIAL A/S and NOVO ENZYM A/S. The management consists of Lisbet Kragelund. The board consists of Mikkel Viltoft (chair), Lisbet Kragelund and Rainer Chapour Lehmann. The company is owned by NOVOZYMES A/S. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -52,056 and a net result of DKK -44,180 compared with DKK -41,700 the year before. Equity in the 2025 report amounted to DKK 24,891,057.